Michael Hamilton's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
Michael Hamilton
President and Chief Executive Officer
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
22
Since Nov 2021
36
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Janice Charette · Chief Trade Negotiator to the United States, Privy Council Office (PCO)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
Official report
Madeleine Féquière · Consul General of Canada in Chicago, Global Affairs Canada (GAC)
Julien Rosen · Trade Commissioner, Life Sciences, Global Affairs Canada (GAC)
Cory Olishansky · Consul and Trade Commissioner, Global Affairs Canada (GAC)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
Official report
Carlos Vanderloo · Counsellor - Economic and Trade Policy, Global Affairs Canada (GAC)
Kaitlyn Pritchard · Trade Program Manager, Innovation & Industrial Policy, Global Affairs Canada (GAC)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
Official report
Martin Moen · Associate Asst Dep. Minister of International Trade and Chair of the Canada/U.S. Trade and Economic Task Force, Global Affairs Canada (GAC)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
Read more
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Ajay Nandalall · Senior Special Assistant, Global Affairs Canada (GAC)
export permits and export controls
Official report
Ajay Nandalall · Senior Special Assistant, Global Affairs Canada (GAC)
export permits and export controls
Official report
Taras Zalusky · Chief of Staff, Global Affairs Canada (GAC)
Ajay Nandalall · Senior Special Assistant, Global Affairs Canada (GAC)
Borna Najafi · Special Assistant - Executive Assistant, Global Affairs Canada (GAC)
export permits and export controls
Official report
Manuela Tomic · Sr Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
Official report
Yasir Naqvi · Parliamentary Secretary to the Minister of International Trade and Parliamentary Secretary to the Secretary of State (International Development), Global Affairs Canada (GAC)
export permits and export controls
Official report
Yasir Naqvi · Parliamentary Secretary, Global Affairs Canada (GAC)
export permits and export controls
Official report
Anita Anand · Minister, Global Affairs Canada (GAC)
Marjorie Michel · Minister, Health Canada (HC)
David Morrison · Deputy Minister, Global Affairs Canada (GAC)
Nathalie G. Drouin · Deputy Clerk of the Privy Council and National Security and Intelligence Advisor to the Prime Minister, Privy Council Office (PCO)
export permits and export controls
Official report
Charles Sousa · Member of Parliament
export permits and export controls
Official report
Yasir Naqvi · Parliamentary Secretary, Global Affairs Canada (GAC)
export permits and export controls
Official report
Taras Zelusky · Chief of Staff, Global Affairs Canada (GAC)
Ajay Nandalall · Senior Advisor, Global Affairs Canada (GAC)
Lisa Jorgensen · Senior Advisor, Prime Minister's Office (PMO)
Scott gilmore · Senior Advisor, Prime Minister's Office (PMO)
export permits and export controls
Official report
Yasir Naqvi · Parliamentary Secretary, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
David Morrison · Deputy Minister, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Lisa Jorgensen · Policy Director, Global Affairs, Prime Minister's Office (PMO)
Scott Gilmore · Senior Advisor on Foreign, Defence, and Security Policy, Prime Minister's Office (PMO)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Jade Mallette · Chief of Staff, Health Canada (HC)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Leslie Scanlon · Ambassador Extraordinary and Plenipotentiary to the State of Israel, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Ajay Nandallal · Senior Advisor, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Taras Zelusky · Chief of Staff, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure;
• Government policy considerations on health data trust and privacy.
Official report
Danielle Boyle · Director of Operations, Finance Canada (FIN)
Support from ISED, with respect to Strategic Innovation Fund
Official report
Greg Orencsak · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Ministry, Health Canada (HC)
Engage in pre-market and post-market regulatory requirements to ensure efficient and predictable processes that supports safety, effectiveness, quality, and Canada’s competitiveness in the medical device sector.
Read more
Official report
Greg Orencsak · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Ministry, Health Canada (HC)
Engage in pre-market and post-market regulatory requirements to ensure efficient and predictable processes that supports safety, effectiveness, quality, and Canada’s competitiveness in the medical device sector.
Read more
Official report
Page 1
Older →
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.
Glossary
Compare bills
★ My bills
Data from LEGISinfo ,
the House of Commons
and Open North's Represent .
Proposed changes are the opening summary printed with each bill. The other lines are built from the bill's listed title and status.
Lobbying data from the Office of the Commissioner of Lobbying .
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying .